Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Amgen,Denosumab,"Osteoporosis, contraindicated to or unable to tolerate bisphosphonates",Denosumab (Prolia),Community and Hospital,Musculoskeletal System
